Brief: Seres Provides Program And Corporate Updates And Prioritizes Emerging Programs In Inflammatory & Immune Diseases

Seres Therapeutics

12/02/2026 12:26

Feb 12 (Reuters) - Seres Therapeutics Inc MCRB.O:

SERES PROVIDES PROGRAM AND CORPORATE UPDATES AND PRIORITIZES EMERGING PROGRAMS IN INFLAMMATORY & IMMUNE DISEASES

SERES THERAPEUTICS INC: COMPANY'S RUNWAY EXTENSION ACTIONS, INCLUDING REDUCING WORKFORCE BY APPROXIMATELY 30%

SERES THERAPEUTICS INC: EXPECTS TO EXTEND ITS CASH RUNWAY THROUGH Q3 OF 2026

Source text: ID:nGNX3kgRxF

Further company coverage: MCRB.O

 ((Reuters.Briefs@thomsonreuters.com;))